To evaluate p53 functional status in cancer-associated pancreatic stellate cells (caPSCs), we isolated fibroblasts from 8 different patients with pancreatic ductal adenocarcinoma and treated the cells with Nutlin-3a or its inactive enantiomer Nutlin-3b. The gene discussed is TP53; the disease is pancreatic ductal adenocarcinoma.